Screener
Idexx Laboratories IDXX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Idexx Laboratories’s reported figures.
The source filing: Idexx Laboratories’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 4:14 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000874716-26-000076
FAQ
- What is Idexx Laboratories's EBITDA?
- Idexx Laboratories (IDXX) reported EBITDA of $400.27M in Q1 2026.
- How has Idexx Laboratories's EBITDA changed year-over-year?
- Idexx Laboratories's EBITDA increased by 14.2% year-over-year, from $350.6M to $400.27M.
- What is the long-term trend for Idexx Laboratories's EBITDA?
- Over 4 years (2021 to 2025), Idexx Laboratories's EBITDA has grown at a 9.8% compound annual growth rate (CAGR), from $1.04B to $1.51B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Idexx Laboratories's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude